{"version":"1.0","type":"link","title":"Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study.","author_name":"Chen M 외","author_url":"https://prs-insight.online/author/Chen%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97300","thumbnail_width":1200,"thumbnail_height":630}